Sign in
4

Changes in Ownership

Evommune, Inc. Filed Acc 0002092017-25-000005

Options or other derivatives

  • Chief Scientific Officer acquired 179,619 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I In the form
Derivatives
Patel Jeegar Pravinkumar Chief Scientific Officer 2025-11-05 Grant or award · Employee Stock Option (Right to Buy) +179,619 179,619 D
Loading xslF345X05/form4-11072025_041109.xml…